These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

92 related items for PubMed ID: 2852446

  • 1. Stimulation of D1 dopamine receptors reveals direct effects of the preferential dopamine autoreceptor agonist B-HT 920 on postsynaptic dopamine receptors.
    Andén NE, Grabowska-Andén M.
    Acta Physiol Scand; 1988 Oct; 134(2):285-90. PubMed ID: 2852446
    [Abstract] [Full Text] [Related]

  • 2. Stimulation of postsynaptic D2- dopamine receptors by B-HT 958 is revealed by co-treatment with the D1- receptor agonist SKF 38393.
    Andén NE, Grabowska-Andén M.
    J Pharm Pharmacol; 1989 Jul; 41(7):490-2. PubMed ID: 2570858
    [Abstract] [Full Text] [Related]

  • 3. Concomitant D1 dopamine receptor activation (SKF 38393) unmasks D2 dopaminergic actions of B-HT 920 in mice.
    Verma A, Kulkarni SK.
    Indian J Exp Biol; 1991 Feb; 29(2):123-6. PubMed ID: 1831182
    [Abstract] [Full Text] [Related]

  • 4. Dopamine receptor mediated antidepressant action of B-HT 920 in mice.
    Sharma A, Kulkarni SK.
    Indian J Exp Biol; 1994 Mar; 32(3):172-5. PubMed ID: 8070836
    [Abstract] [Full Text] [Related]

  • 5. Behavioural role of dopamine D1 receptors in the reserpine-treated mouse.
    Starr BS, Starr MS, Kilpatrick IC.
    Neuroscience; 1987 Jul; 22(1):179-88. PubMed ID: 2957609
    [Abstract] [Full Text] [Related]

  • 6. The dopamine autoreceptor agonist B-HT 920 stimulates denervated postsynaptic brain dopamine receptors in rodent and primate models of Parkinson's disease: a novel approach to treatment.
    Hinzen D, Hornykiewicz O, Kobinger W, Pichler L, Pifl C, Schingnitz G.
    Eur J Pharmacol; 1986 Nov 12; 131(1):75-86. PubMed ID: 3816949
    [Abstract] [Full Text] [Related]

  • 7. Motor actions of 7-OH-DPAT in normal and reserpine-treated mice suggest involvement of both dopamine D2 and D3 receptors.
    Starr MS, Starr BS.
    Eur J Pharmacol; 1995 Apr 24; 277(2-3):151-8. PubMed ID: 7493603
    [Abstract] [Full Text] [Related]

  • 8. B-HT 920 stimulates postsynaptic D2 dopamine receptors in the normal rat: electrophysiological and behavioral evidence.
    Johansen PA, Clarkl D, White FJ.
    Life Sci; 1988 Apr 24; 43(6):515-24. PubMed ID: 2900459
    [Abstract] [Full Text] [Related]

  • 9. B-HT 920 is a full agonist at both pre- and postsynaptic D-2 dopamine receptors.
    Andén NE, Grabowska-Andén M.
    J Neural Transm Gen Sect; 1990 Apr 24; 79(3):209-14. PubMed ID: 2136999
    [Abstract] [Full Text] [Related]

  • 10. Dopamine D1 receptor involvement in the discriminative-stimulus effects of SKF 81297 in squirrel monkeys.
    Rosenzweig-Lipson S, Bergman J.
    J Pharmacol Exp Ther; 1993 Nov 24; 267(2):765-75. PubMed ID: 7902432
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dopamine receptor mediated hypothermic action of B-HT 920 in rats.
    Verma A, Kulkarni SK.
    J Pharm Pharmacol; 1991 Jun 24; 43(6):421-4. PubMed ID: 1681056
    [Abstract] [Full Text] [Related]

  • 13. On the characterization of dopamine-induced contractile response of rat anococcygeus muscle preparation.
    Sharma A, Kulkarni SK.
    Indian J Exp Biol; 1994 Mar 24; 32(3):176-9. PubMed ID: 8070837
    [Abstract] [Full Text] [Related]

  • 14. Behavioural interactions involving D1 and D2 dopamine receptors in non-habituated mice.
    Starr BS, Starr MS.
    Neuropharmacology; 1987 Jun 24; 26(6):613-9. PubMed ID: 2955244
    [Abstract] [Full Text] [Related]

  • 15. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT, White FJ.
    Synapse; 1992 Mar 24; 10(3):206-16. PubMed ID: 1532677
    [Abstract] [Full Text] [Related]

  • 16. Characterization of unconditioned behavioral effects of dopamine D3/D2 receptor agonists.
    Geter-Douglass B, Katz JL, Alling K, Acri JB, Witkin JM.
    J Pharmacol Exp Ther; 1997 Oct 24; 283(1):7-15. PubMed ID: 9336302
    [Abstract] [Full Text] [Related]

  • 17. Behavioral differentiation of the stimulus properties of a dopaminergic D1 agonist from a D2 agonist.
    Cory-Slechta DA, Widzowski DV, Newland MC.
    J Pharmacol Exp Ther; 1989 Sep 24; 250(3):800-8. PubMed ID: 2789282
    [Abstract] [Full Text] [Related]

  • 18. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
    Rouillon C, Abraini JH, David HN.
    Hippocampus; 2007 Sep 24; 17(11):1028-36. PubMed ID: 17604350
    [Abstract] [Full Text] [Related]

  • 19. Effect of D1- and D2-dopamine agonists on neocortical and hippocampal EEG activity of rat brain: modulation of rimcazole effect.
    Verma A, Kulkarni SK, Nayar U.
    Methods Find Exp Clin Pharmacol; 1993 Oct 24; 15(8):515-25. PubMed ID: 7905945
    [Abstract] [Full Text] [Related]

  • 20. Increased motor activity following combined stimulation of B-HT 920-sensitive and D-1 dopamine receptors.
    Andén NE, Grabowska-Andén M.
    Acta Physiol Scand; 1987 Sep 24; 131(1):157-8. PubMed ID: 2890261
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.